The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a grant to the Duke University’s Duke Translational Medicine Institute (DTMI) to support
credit:
the Clinical Trials Transformation Initiative (CTTI).